Wetenschappelijke publicaties van Erasme

Wetenschappelijke publicaties van Erasme

  • Prevalence of Hidradenitis Suppurativa: A Meta-Analysis of Global Hidradenitis Suppurativa Atlas Studies.

  • Auteurs Bouazzi D, Nielsen SM, Hagan PG, Botvid S, Hove LS, Prens EP, Christensen R, Jemec GBE, Knecht-Gurwin K, Szepietowski JC, Anaba EL, Chehad AS, Zobiri S, Serradj A, Bhuiyan MSI, Noor T, Guillem P, Parvizi MM, Saki N, Alpsoy E, Vardar C, Kanni T, Giamarellos-Bourboulis EJ, Frew JW, Al Maharbi WHA, van Huijstee JC, Aarts P, Dewi ST, Febriana SA, Indrastuti N, Suryawati N, Pangastuti M, Adji A, Akhyar G, Nopriyati N, Hazlianda CP, Reyes-Baraona F, Matas C, Saeed H, Moodley A, Binamer Y, Kamil MAA, Jocic I, Mijuskovic Z, Mallawaarachchi K, Gangani C, Tusheva I, Boshkovski VB, Hu D, Geng S, Medianfar CE, Saunte DML, Chandran NS, van der Zee HH, Zouboulis CC, Benhadou F, Villumsen B, Alavi A, Ibekwe PU, Hamzavi IH, Ingram JR, Naik HB, Garg A, Boer J
  • Revue JAMA Dermatol
  • Date de publication 2025-08
Prevalence of Hidradenitis Suppurativa: A Meta-Analysis of Global Hidradenitis Suppurativa Atlas Studies.
  • Identifying and overcoming barriers to referral in advanced heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC.

  • Auteurs Baudry G, Crespo-Leiro MG, Delmas C, Guidetti F, Bravo MJ, Valente F, Cikes M, Girerd N, Gustafsson F, Savarese G, van Laake LW, Hill L, Skibelund AK, Zuckermann A, Metra M, Damman K
  • Revue Eur J Heart Fail
  • Date de publication 2025-08
Identifying and overcoming barriers to referral in advanced heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC.
  • Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study.

  • Auteurs Sitbon O, Sahay S, Escribano Subías P, Zolty RL, Kingrey JF, Ryan JJ, Sobol I, Sood N, Benza RL, Channick RN, Chin KM, Frantz RP, Ghofrani HA, Hemnes AR, McLaughlin VV, Vachiéry JL, Zamanian RT, Ter Veer A, Roscigno RF, Mottola D, Parsley E, Aranda R, Zisman LS, Howard LS
  • Revue Adv Ther
  • Date de publication 2025-08
Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study.
  • Standard complete blood count to predict long-term outcomes in febrile infection-related epilepsy syndrome (FIRES): A multicenter study.

  • Auteurs Guillemaud M, Hanin A, Riviello JJ, Chavez M, Batra A, Berry M, Bisulli F, Castillo-Pinto C, Cobos-Hernandez C, Demeret S, Eschbach K, Farias-Moeller R, Fields M, Gaspard N, Gerard EE, Gofton TE, Gopaul MT, Gruen MD, Jimenez AD, Kazazian K, Kim M, Mansour M, Marcuse L, Marois C, Morales M, Muccioli L, Pasini E, Pham MM, Rosas SP, Struck AF, Torcida N, Wainwright MS, Yoo JY, Muscal E, Navarro V, Hirsch LJ, Lai Y
  • Revue Epilepsia
  • Date de publication 2025-08
Standard complete blood count to predict long-term outcomes in febrile infection-related epilepsy syndrome (FIRES): A multicenter study.
  • Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis.

  • Auteurs Merkel PA, Nair PK, Khalidi N, Terrier B, Hellmich B, Bourdin A, Jayne DRW, Jackson DJ, Roufosse F, Pagnoux C, Specks U, Börjesson Sjö L, Ho CN, Jison M, McCrae C, Necander S, Rodríguez-Suárez E, Shavit A, Walton C, Wechsler ME
  • Revue Ann Rheum Dis
  • Date de publication 2025-08
Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis.
Huderf hospital

Queen Fabiola Kinderziekenhuis

Bekijk alle wetenschappelijke publicaties van het Koningin Fabiola Kinderziekenhuis

Bordet hospital

Jules Bordet-instituut

Bekijk alle wetenschappelijke publicaties van Jules Bordet

Decorative image of doctor and patient

Alle wetenschappelijke publicaties van het H.U.B.

Bekijk alle wetenschappelijke publicaties van het H.U.B.